Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. 1989

K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
Institute for Molecular and Cellular Biology, Osaka University, Japan.

Polyclonal B cell activation is commonly observed in AIDS and in infection with HIV. The effect of HIV on the induction of B cell stimulatory factor 2 (BSF-2) production was examined, since BSF-2 plays an essential role in the differentiation of activated B cells to Ig-secreting cells. Increased BSF-2 mRNA levels and increased BSF-2 secretion were observed soon after exposure of mononuclear cells isolated from healthy donors to both "live" and inactivated HIV. HIV-induced BSF-2 production was seen in monocyte/macrophages, but not in T cells. These results suggest that the HIV-induced overproduction of BSF-2 might contribute to the polyclonal B cell activation seen in AIDS and in infection with HIV.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent

Related Publications

K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
January 1989, Journal of biological regulators and homeostatic agents,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
June 1988, Journal of immunology (Baltimore, Md. : 1950),
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
January 1989, Annals of the New York Academy of Sciences,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
June 1988, Biochemical and biophysical research communications,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
August 1988, Molecular and cellular biology,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
October 1987, The EMBO journal,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
November 1988, European journal of immunology,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
August 1989, Clinical immunology and immunopathology,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
February 1989, FEBS letters,
K Nakajima, and O Martínez-Maza, and T Hirano, and E C Breen, and P G Nishanian, and J F Salazar-Gonzalez, and J L Fahey, and T Kishimoto
June 1988, European journal of immunology,
Copied contents to your clipboard!